BCIQ Profiles

Company Profile Report
0430 Werewolf Vaccitech IPOs
BioCentury & Getty Images

Finance

Werewolf, Vaccitech IPOs signal continued appetite for fresh biotech paper

Divergent aftermarket performances for NASDAQ’s newest biotechs

A third of the way through 2021, appetite for new biopharma listings has allowed biopharmas to raise more than three

Read the full 437 word article

How to gain access

Continue reading with a
two-week free trial.